钻孔置管引流联合尿激酶治疗硬膜外血肿的临床疗效

Clinical observation of the treatment of Subextradural hematoma by Puncture and drainage combined with Urokinase

目的观察钻孔置管引流联合尿激酶治疗硬膜外血肿的临床疗效,评价预后。方法回顾分析80例硬膜外血肿患者进行钻孔置管引流联合尿激酶治疗的临床资料、手术方法和治疗效果。结果所有患者未因术中因出血而改为开颅起骨瓣血肿清除术,所有患者均引流满意。定期复查头颅CT显示,血肿在1～4d基本清除,平均2.1d。住院时间6～20d,平均l0.8d。3个月后门诊随访,GCS评分:恢复良好70例,轻度残疾8例,重度残疾2例。结论钻孔置管引流联合尿激酶治疗硬膜外血肿的临床疗效确切,手术创伤小、操作简便,是硬膜外血肿行之有效的治疗方法。

Objective To evaluate the effects of the treatment of Subextradural hematoma by Puncture and drainage combined with Urokinase,and to evaluate of prognosis. Methods To retrospective analyze the clinical data of Subextradural hematoma patients in our hospita1,to explore the effect of surgical treatment and the surgical methods. Among 80 cases of patients with epidural hematoma drilling catheter drainage combined with urokinase treatment. Results All patients were not due to intraoperative bleeding into the bone flap craniotomy hematoma removal,all patients with drainage of satisfaction. Head CT shows,periodic review of basic clear hematoma in 1 to 4 days,the average day of 2.1.6 to 20 days length of hospital stay,the average day of l0.8. After 3 months follow-up outpatient,GCS score： 70 cases recovered well,mild disability in 8 cases,2 cases of severe disability. Conclusion The clinical curative effect of the treatment of Subextradural hematoma patients by Puncture and drainage combined with Urokinase is patency,Puncture and drainage combined with Urokinase is a feasible methods for Subextradural hematoma patients,which with less complication and injury, prognosis is good,which is to be used.